BEGIN:VCALENDAR PRODID;X-RICAL-TZSOURCE=TZINFO:-//Calagator//EN CALSCALE:GREGORIAN X-WR-CALNAME:Calagator METHOD:PUBLISH VERSION:2.0 BEGIN:VTIMEZONE TZID;X-RICAL-TZSOURCE=TZINFO:America/Los_Angeles BEGIN:DAYLIGHT DTSTART:20120311T020000 RDATE:20120311T020000 TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT CREATED;VALUE=DATE-TIME:20120327T231456Z DTEND;TZID=America/Los_Angeles;VALUE=DATE-TIME:20120524T093000 DTSTART;TZID=America/Los_Angeles;VALUE=DATE-TIME:20120524T073000 DTSTAMP;VALUE=DATE-TIME:20120327T231456Z LAST-MODIFIED;VALUE=DATE-TIME:20120327T231456Z UID:http://calagator.org/events/1250462177 DESCRIPTION:The Research and Development Tax Credit – Benefits\, Caveat s\, and Strategies\n\nRecently\, The Fiscal Times identified the researc h and development tax credit as #8 of the 10 largest big corporate tax b reaks*. Although over 17\,000 companies claim this credit nationwide\, 1 00 large multinationals receive over half of the 7+ billion dollars in s avings each year. Find out what your company can do to receive the same level of benefit the Fortune 100 have been receiving for years. \n\nMany medical device\, software\, and biotech companies eligible to benefit handsomely from this credit have never applied for it\, or are only rece iving a small fraction of what they are eligible for. R&\;D credits r eimburse the costs associated with a company’s breakthroughs\, as well as the day-to-day activities that bring improvements in products\, soft ware\, processes\, profits\, and productivity. The research and developm ent credit was enacted to encourage innovation\, and applies to activiti es throughout an organization – from conceptualization\, prototyping a nd production\, through testing and the planning of quality control.\n\n Specific coverage will include:\n\nIdentifying qualifying activities thr oughout your company.\n\nEarly stage companies - why it is never too ear ly to claim the credit. \n\nHow to effectively lower the cost of process improvement\, product testing\, patent applications\, and other activit ies not commonly considered as R&\;D. \n\nCredits for contract manufa cturing – the companies who design devices and create software aren’ t the only ones eligible. \n\nPotential risks and strategies for getting the most out of the credit.\n\nWho should attend:\n\nCFO’s\, controll ers\, in-house counsel\, and others involved in financial management. \n \nAccountants and tax attorneys. \n\nCompany owners\, angel investors\, venture capitalists\, seed fund managers\, and other investors looking t o maximize their investment returns. \n\nPatent attorneys\, operational consultants\, Lean gurus\, and test\, and design firms interested in edu cating their clients on a credit that can effectively lower their servic e costs.\n\n\nTags: software\, r&d\, tax\, tax credit\, incentives\, bio tech\, medical device\, software as a service\n\nImported from: http://c alagator.org/events/1250462177 URL:http://www.oregonbio.org/Events/CFOSeminarSeries/tabid/332/Default.as px SUMMARY:R&D Tax Credits for Software and Biotech Companies LOCATION:Portland State Business Accelerator Mt. Hood room: 2828 SW Corb ett Street\, Portland Oregon 97201 US SEQUENCE:2 END:VEVENT END:VCALENDAR